KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Convertible Debt: 2011-2015

Historic Convertible Debt for Regeneron Pharmaceuticals (REGN) over the last 4 years, with Sep 2015 value amounting to $30.7 million.

  • Regeneron Pharmaceuticals' Convertible Debt fell 89.33% to $30.7 million in Q3 2015 from the same period last year, while for Sep 2015 it was $30.7 million, marking a year-over-year decrease of 89.33%. This contributed to the annual value of $146.8 million for FY2014, which is 54.18% down from last year.
  • Per Regeneron Pharmaceuticals' latest filing, its Convertible Debt stood at $30.7 million for Q3 2015, which was up 1.20% from $30.4 million recorded in Q2 2015.
  • Regeneron Pharmaceuticals' Convertible Debt's 5-year high stood at $326.7 million during Q1 2014, with a 5-year trough of $30.4 million in Q2 2015.
  • In the last 3 years, Regeneron Pharmaceuticals' Convertible Debt had a median value of $287.9 million in 2014 and averaged $226.7 million.
  • As far as peak fluctuations go, Regeneron Pharmaceuticals' Convertible Debt rose by 8.07% in 2014, and later tumbled by 89.33% in 2015.
  • Quarterly analysis of 5 years shows Regeneron Pharmaceuticals' Convertible Debt stood at $275.0 million in 2011, then grew by 7.82% to $296.5 million in 2012, then rose by 8.03% to $320.3 million in 2013, then crashed by 54.18% to $146.8 million in 2014, then slumped by 89.33% to $30.7 million in 2015.
  • Its Convertible Debt was $30.7 million in Q3 2015, compared to $30.4 million in Q2 2015 and $144.1 million in Q1 2015.